These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 35783563

  • 1. Risk of Skin Cancer with Phototherapy in Moderate-to-Severe Psoriasis: An Updated Systematic Review.
    Thatiparthi A, Martin A, Liu J, Wu JJ.
    J Clin Aesthet Dermatol; 2022 Jun; 15(6):68-75. PubMed ID: 35783563
    [Abstract] [Full Text] [Related]

  • 2. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [Abstract] [Full Text] [Related]

  • 3. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC, Jeanmougin M.
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():11-21. PubMed ID: 22512676
    [Abstract] [Full Text] [Related]

  • 5. No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: a first retrospective study.
    Weischer M, Blum A, Eberhard F, Röcken M, Berneburg M.
    Acta Derm Venereol; 2004 May; 84(5):370-4. PubMed ID: 15370703
    [Abstract] [Full Text] [Related]

  • 6. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
    Lin TL, Wu CY, Chang YT, Juan CK, Chen CC, Yu SH, Chen YJ.
    Photodermatol Photoimmunol Photomed; 2019 May; 35(3):164-171. PubMed ID: 30536640
    [Abstract] [Full Text] [Related]

  • 7. A review of phototherapy protocols for psoriasis treatment.
    Lapolla W, Yentzer BA, Bagel J, Halvorson CR, Feldman SR.
    J Am Acad Dermatol; 2011 May; 64(5):936-49. PubMed ID: 21429620
    [Abstract] [Full Text] [Related]

  • 8. What is the most common phototherapy prescription for psoriasis: NB-UVB or PUVA? Prescription behavior.
    Duarte I, Cunha JA, Bedrikow RB, Lazzarini R.
    An Bras Dermatol; 2009 Jul; 84(3):244-8. PubMed ID: 19668937
    [Abstract] [Full Text] [Related]

  • 9. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
    Wang E, Ahad T, Liu YA, Lee TK, Lui H, Crawford RI, Kalia S.
    J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
    [Abstract] [Full Text] [Related]

  • 10. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
    Karaosmanoglu N, Ozdemir Cetinkaya P, Kutlu O, Karaaslan E, Imren IG, Kiratli Nalbant E, Eksioglu M.
    Arch Dermatol Res; 2020 May; 312(4):249-253. PubMed ID: 31729594
    [Abstract] [Full Text] [Related]

  • 11. Narrowband UVB phototherapy for the treatment of psoriasis: a review and update.
    Barbagallo J, Spann CT, Tutrone WD, Weinberg JM.
    Cutis; 2001 Nov; 68(5):345-7. PubMed ID: 11766120
    [Abstract] [Full Text] [Related]

  • 12. Treatments for psoriasis and the risk of malignancy.
    Patel RV, Clark LN, Lebwohl M, Weinberg JM.
    J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
    [Abstract] [Full Text] [Related]

  • 13. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study.
    Asawanonda P, Nateetongrungsak Y.
    J Am Acad Dermatol; 2006 Jun; 54(6):1013-8. PubMed ID: 16713455
    [Abstract] [Full Text] [Related]

  • 14. UVB phototherapy and skin cancer risk: a review of the literature.
    Lee E, Koo J, Berger T.
    Int J Dermatol; 2005 May; 44(5):355-60. PubMed ID: 15869531
    [Abstract] [Full Text] [Related]

  • 15. Distinguishing Myth from Fact: Photocarcinogenesis and Phototherapy.
    Thompson KG, Kim N.
    Dermatol Clin; 2020 Jan; 38(1):25-35. PubMed ID: 31753190
    [Abstract] [Full Text] [Related]

  • 16. Phototherapy of psoriasis: review and update.
    Kostović K, Pasić A.
    Acta Dermatovenerol Croat; 2004 Jan; 12(1):42-50. PubMed ID: 15095760
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacy of local narrowband ultraviolet B (NB-UVB) phototherapy versus psoralen plus ultraviolet A (PUVA) paint for palmoplantar psoriasis.
    Sezer E, Erbil AH, Kurumlu Z, Taştan HB, Etikan I.
    J Dermatol; 2007 Jul; 34(7):435-40. PubMed ID: 17584319
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis.
    Dawe RS, Cameron H, Yule S, Man I, Wainwright NJ, Ibbotson SH, Ferguson J.
    Br J Dermatol; 2003 Jun; 148(6):1194-204. PubMed ID: 12828749
    [Abstract] [Full Text] [Related]

  • 19. A Perspective on the Use of NB-UVB Phototherapy vs. PUVA Photochemotherapy.
    Ibbotson SH.
    Front Med (Lausanne); 2018 Jun; 5():184. PubMed ID: 30013973
    [Abstract] [Full Text] [Related]

  • 20. Retrospective study of the efficacy of narrowband UVB and acitretin.
    Spuls PI, Rozenblit M, Lebwohl M.
    J Dermatolog Treat; 2003 Jun; 14 Suppl 2():17-20. PubMed ID: 14578094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.